HDFC Mutual Fund Acquires More Global Health Shares in ₹130 Crore Deal

HDFC Mutual Fund has significantly increased its stake in Global Health, the parent company of the renowned Medanta hospital chain, through a major open market transaction. This strategic move underscores the fund manager's growing confidence in the healthcare sector and the company's robust financial trajectory.

Details of the Block Deal and Stake Acquisition

In a significant transaction executed through the BSE, HDFC Mutual Fund purchased an additional 10 lakh shares of Global Health. The deal was valued at approximately ₹130 crore, with the shares being acquired at an average price of ₹1,300 per share. This transaction represents a 0.37 per cent stake in the healthcare major.

The shares were offloaded by Sunil Sachdeva, a co-founder of Medanta Hospitals. As of the end of the March quarter, Sachdeva held a substantial stake of 10.79 per cent in the company, comprising 2.90 crore equity shares. This latest transaction follows a similar move by HDFC Mutual Fund last month, where the fund had acquired another 10 lakh shares from Sachdeva for over ₹122 crore.

Strong Financial Performance Driving Investor Interest

The increased interest from institutional investors like HDFC Mutual Fund comes on the back of impressive quarterly earnings reported by Global Health. For the fourth quarter ended March 31, 2026, the company reported a significant 39.7 per cent surge in Profit After Tax (PAT), reaching ₹141.7 crore. This is a sharp rise from the ₹101.4 crore recorded in the corresponding period of the previous fiscal year.

Furthermore, the company's operational efficiency is reflected in its top-line growth. Revenue from operations for the Q4 period stood at ₹1,159 crore, compared to ₹931.3 crore in the previous year. This robust growth in both revenue and profitability highlights the scaling capabilities of the Medanta brand in the competitive Indian healthcare landscape.

Market Reaction and Sector Outlook

Despite the large-scale transaction and the positive underlying fundamentals, the stock market showed a cautious immediate reaction. Shares of Global Health saw a marginal decline of 0.41 per cent, closing at ₹1,311.35 apiece on the BSE.

For business professionals and investors, HDFC Mutual Fund's repetitive buying pattern suggests a long-term bullish outlook on the healthcare services segment. The ability of Global Health to maintain high double-digit growth in both profit and revenue makes it a key player to watch in the evolving Indian medical infrastructure sector.

Key Takeaways

  • Strategic Accumulation: HDFC Mutual Fund has increased its stake in Global Health by 0.37% through a ₹130 crore purchase of 10 lakh shares at ₹1,300 per share.
  • Robust Growth Metrics: Global Health reported a nearly 40% increase in quarterly PAT to ₹141.7 crore, driven by a significant rise in operational revenue to ₹1,159 crore.
  • Founder Divestment: The shares were acquired from co-founder Sunil Sachdeva, marking the second major block deal between him and HDFC MF in recent months.